secwatch.observer — SEC 8-K summary
======================================

Issuer:     NutriBand Inc. (NTRB)
CIK:        0001676047
Form:       8-K
Filed at:   2025-02-13T23:59:59+00:00
Accession:  0001213900-25-013266
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nutriband formalizes exclusive Aversa Fentanyl partnership with Kindeva; potential $80-200M US sales
--------------------------------------------------------------------------------

- Signed addendum formalizing exclusive development partnership for Aversa Fentanyl with Kindeva Drug Delivery.
- Partnership based on shared development costs in exchange for milestone payments.
- Aversa Fentanyl combines Nutriband's abuse-deterrent technology with Kindeva's FDA-approved fentanyl patch.
- Estimated peak annual US sales potential of $80M to $200M.
- AVERSA technology protected by patents in 46 countries including US, Europe, Japan.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1676047/000121390025013266/0001213900-25-013266-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1676047/000121390025013266/ea0231002-8k_nutriband.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-013266

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer